<DOC>
	<DOCNO>NCT02977247</DOCNO>
	<brief_summary>The SoftVue™ whole breast ultrasound system automate scan curvilinear ring‐array transducer employ UST . It currently clear FDA 510 ( k ) K123209 K142517 use B‐mode ultrasonic breast imaging system color image transmission data ( sound speed attenuation ) . SoftVue™ intend use replacement screen mammography . SoftVue use non‐ionizing ultrasound energy generate tomographic image volume whole breast . While patient lay prone pad table one breast comfortably submerge bath warm water , ring‐shaped transducer , 22 cm diameter , encircle breast pulse low‐frequency sound wave water breast tissue . More 2000 element curvilinear transducer 's 360 degree array emit receive ultrasound signal analyze echo breast anatomy direction , chest wall nipple . Not SoftVue capture data reflection sound wave tissue boundary structure within breast , transducer surround whole breast , SoftVue also capture signal transmit breast . This additional transmission data enhances visualization anatomic structure breast tissue currently available commercially market breast ultrasound device . This prospective , multicenter , multi‐arm , clinical case collection program IRB‐approved conduct compliance Good Clinical Practice , Declaration Helsinki applicable regulatory requirement . Arm 2 aim collectively enroll 1,000 woman total 8 clinical site . The design Arm 2 protocol strictly limit case collection non-interventional ; investigational and/or statistical plan future analysis prepare registered separately , applicable requirement FDAAA 801 . Arm 2 limited cohort diagnostic female patient breast density composition category , recommend breast biopsy ( BI-RADS 4 5 ) diagnostic imaging , confirm imaging finding . Matched set diagnostic image SV exam , patient , demographic information , clinical outcome data , collect diagnostic workup . Ultrasound characteristic type lesion , whether benign malignant , collect well objective subjective breast density composition data . Ultrasound image data may acquire modify SoftVue device , pass safety quality evaluation per Delphinus ' quality management system ( QMS ) satisfy design change control standard , select clinical site accordance 21 CFR 812.2 ( b ) , routine part feasibility , validation , verification test engineering product development purpose . The exams clinical data accumulate prospective case collection ( PCC ) protocol populate database future investigation may design peer review publication , development user training curriculum , build teach case , create new marketing material SoftVue .</brief_summary>
	<brief_title>Delphinus SoftVue Prospective Case Collection - ARM 2</brief_title>
	<detailed_description>MEDICAL DEVICES : - SoftVue™ ( SV ) automate whole breast ultrasound system , 510 ( k ) Cleared B‐Mode ultrasound breast imaging , manufacture Delphinus Medical Technologies . - SoftVue™ device modification ( software , hardware , user‐interface ) , safety‐tested human use complete feasibility , verification , validation test routine part product development perform accordance FDA 21 CFR 812.2 ( b ) , manufacture Delphinus Medical Technologies . - Full‐field digital mammography ( FFDM ) , FDA Approved breast screen diagnosis , various manufacturer . ( If clinically indicate ) - Digital breast tomosynthesis ( DBT ) , FDA Approved breast screen diagnosis , various manufacturer . - Handheld Ultrasound ( HHUS ) , FDA-Cleared diagnostic breast imaging , various manufacturer . ( If clinically indicate ) - Other diagnostic test medical device examination breast , include , limited MRI , BSGI , PET , biopsy , elastography , order license physician , clinically indicate . OBJECTIVES : - Primary : To establish library case use future SoftVue™ research study , user training , marketing . - Secondary : Determine frequency severity adverse event ( AEs ) evaluate safety SoftVue . ENDPOINTS : From multiple clinical site whichever come first : • Up 1,000 total enrol subject SITES : At least six ( ≥ 6 ) qualify clinical site United States - MQSA Certified - Digital Breast Tomosynthesis Screening Program Implemented - Academic , Community Hospital , Private Practice Setting PROJECT DESIGN AND PROCEDURES : - Potential participant recruit group woman present diagnostic evaluation biopsy multiple clinical site . - All participant complete standard care diagnostic evaluation recommend physician - Eligible patient receive SV scan time schedule diagnostic appointment , preferably prior biopsy - Investigators sit compare SV image accompany diagnostic image pathology result - No clinical SV interpretation perform clinical intervention make change base SV image - All evaluation result , diagnosis treatment outcomes record - Cancer status participant survey program entry include completion physician recommend diagnostic workup - A case determine cancer negative participant non-malignant breast biopsy finding confirm non-suspicious diagnostic breast imaging finding - A case determine cancer positive pathological evaluation confirms breast cancer diagnosis ( malignancy ) STATISTICAL ANALYSIS : - Demographic characteristic ( age , race , ethnicity ) baseline characteristic ( e.g. , project arm , project site , breast density , lesion‐specific characteristic ) tabulate participant . - A flow diagram table illustrate patient disposition ( `` accountability patient cohort '' ) include reason ineligibility and/or unevaluability . - Safety summarize enrolled woman . With exception anticipate event , adverse event ( AEs ) serious adverse event ( SAEs ) , occur time enrollment ( SoftVue ) 24 hour follow conclusion SoftVue exam , record . - A separate statistical plan develop future analysis include justification sample size , applicable requirement FDAAA 801 , register separately order share result .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Female Any race ethnicity Age 18 old Findings concern clinical breast exam image Scheduled diagnostic imaging , needle biopsy , excisional biopsy , postneedlebiopsy visit Diagnostic imaging assessment category BIRADS 4 5 willing undergo biopsy ( y ) , per Principal Investigator , subject 's case would beneficial use lesion atlas teach library Agrees contact site staff recommend biopsy complete within appropriate time frame Exclusion Criteria Unwilling/unable comply protocol followup recommendation Lumpectomy excisional biopsy primary region interest perform prior SoftVue imaging , sufficient finding make case useful lesion atlas teach library Weight exceed 350lbs Currently pregnant lactate patient self‐report Weeping rash , open wound , unhealed sore breast Bilateral mastectomy Unable lay prone scan table 15 minute</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>SoftVue</keyword>
	<keyword>Dense Breast Tissue</keyword>
	<keyword>Breast Screening</keyword>
	<keyword>Abnormal Breast</keyword>
	<keyword>Normal Breast</keyword>
	<keyword>Breast Imaging</keyword>
	<keyword>Breast Biopsy</keyword>
	<keyword>Mammography</keyword>
	<keyword>Tomosynthesis</keyword>
	<keyword>Automated Breast Ultrasound</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Breast Carcinoma</keyword>
	<keyword>Breast Tumors</keyword>
	<keyword>Mammary Carcinoma</keyword>
	<keyword>Malignant Breast Tumor</keyword>
	<keyword>Mammary Neoplasm</keyword>
	<keyword>Mammary Cancer</keyword>
	<keyword>ABUS</keyword>
	<keyword>AWBUS</keyword>
	<keyword>Breast Tomography</keyword>
	<keyword>ATUS</keyword>
	<keyword>ABTUS</keyword>
	<keyword>Mammogram</keyword>
	<keyword>3D Mammogram</keyword>
	<keyword>3D ABUS</keyword>
	<keyword>3D Breast Ultrasound</keyword>
	<keyword>DBT</keyword>
	<keyword>FFDM</keyword>
	<keyword>Digital Mammography</keyword>
	<keyword>Breast Ultrasound</keyword>
	<keyword>Dense Breasts</keyword>
	<keyword>Breast Density</keyword>
	<keyword>Dense Parenchyma</keyword>
	<keyword>Asymptomatic</keyword>
	<keyword>Delphinus</keyword>
	<keyword>Delphinus Medical Technologies</keyword>
	<keyword>Diagnostic Breast Imaging</keyword>
</DOC>